Guardant Health Q3 2023 Adj EPS $(0.67) Beats $(0.95) Estimate, Sales $143.03M Beat $137.37M Estimate
Portfolio Pulse from saritha@benzinga.com
Guardant Health (NASDAQ:GH) reported Q3 2023 earnings with adjusted EPS of $(0.67), beating the estimate of $(0.95) by 29.47%. The company also reported sales of $143.03M, surpassing the estimate of $137.37M by 4.12%. Both figures represent significant increases from the same period last year.
November 06, 2023 | 9:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Guardant Health's Q3 2023 earnings beat estimates, which could positively impact the company's stock in the short term.
Guardant Health reported better-than-expected Q3 2023 earnings, with both EPS and sales beating estimates. This positive financial performance could increase investor confidence and drive the company's stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100